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Resumo 
 
A falta de estudos epidemiológicos a respeito de determinadas doenças, pode afetar o 
desenvolvimento de determinados programas de prevenção. Na região Norte do Brasil dados 
epidemiológicos sobre as lesões da cavidade bucal são escassos. Em muitos casos os tumores 
malignos são diagnosticados tardiamente em dois ou mais sítios de acometimento. Sendo assim, 
foi realizado um estudo retrospectivo dos prontuários dos pacientes atendidos pelos serviços de 
Cabeça e Pescoço e Odontologia da Fundação Centro e Controle de Oncologia do Estado do 
Amazonas (FCECON) no período de 1998 a 2009. No total foram selecionados 518 prontuários, 
seguindo os seguintes critérios de exclusão: ausência de dados e a impossibilidade de comprovar 
o laudo histopatológico das lesões. Dados a respeito do gênero, idade, raça, local de nascimento e 
residência, hábitos, sitio primário da lesão e o histológico da doença foram coletados. Todos os 
procedimentos estatísticos foram realizados no programa Statistica versão 5.1 (StatSoft Inc., 
Tulsa, USA). Foi observado que o gênero masculino (57,7%) foi predominante e que a média de 
idade dos pacientes foi de 47,8 anos (intervalo de 0 a 92 anos). As neoplasias malignas foram a 
maioria perfazendo 53,3% dos casos, seguidas pelas neoplasia benignas (18,0%) e patologias 
periodontais e gengivais (10,0%). A maioria dos casos dentro das neoplasias malignas foi do 
carcinoma de células escamosas (41,5%, n=215) e dentre as benignas foi o adenoma pleomórfico 
(9,5%, n=49). Uma ampla variedade de lesões foram encontradas e tabuladas para análise. A 
língua (17,8%) e a parótida (12,5%) foram as localidades mais acometidas pelas lesões. Essa 
distribuição varia nas diferentes regiões do Brasil e do mundo. Todos os dados analisados 
mostram que existe a necessidade de planejar novas estratégias para que os profissionais de saúde 
possam identificar precocemente as lesões que atingem o complexo maxilomandibular para 
minimizar possíveis sequelas que possam advir do tratamento e assim trabalhar por uma melhor 
qualidade de vida do paciente. Alem disso, a dificuldade de locomoção pelas barreiras 
geográficas, delimita a procura por atendimento por estes pacientes. 
 
Palavras-chave: epidemiologia, saúde bucal, diagnóstico bucal, carcinoma de células escamosas, 
glândulas salivares. 
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Abstract 
 
The lack of studies on the epidemiology of certain diseases may restrain the development of 
prevention and control programs. In the Northern region of Brazil, epidemiological data on oral 
lesions are rare and, in many cases, malignant tumors are frequently found in more than two sites. 
A retrospective study of patient medical records attended at the Department of Head and Neck 
and Odontology of the Oncology Center Control Foundation of the Amazonas (FCECON) from 
January 1998 to December 2009 was carried to better understand the oral and oropharynx lesions 
occurrence. The present study selected 518 medical records, using as exclusion criteria the lack 
of information and the impossibility to confirm its histopathology. Information concerning 
patient gender, age, race, birthplace, current residence, habits, primary lesion site and histological 
data of the disease were collected. All statistical analysis was done using the software Statistica 
5.1 version (StatSoft Inc., Tulsa, USA). Male patients were more affected by lesions (57.7%) and 
mean age was 47.8 years (range of 0 to 92 years). Malignant neoplasias accounted for 53.3% of 
the cases, followed by benign neoplasia (18.0%) and periodontal and gingival pathologies 
(10.0%). Squamous cell carcinoma (41.5%, n=215) was the most common malignant neoplasia 
and the pleomorphic adenoma (9.5%, n=49) the most common among the benign ones. A wide 
variety of lesions was registered and tabulated for analysis. The tongue (17.8%) and the parotid 
(12.5%) were the primary sites affected by the lesions.  The distribution of neoplasias varies 
according to the region in Brazil and worldwide. The present study highlights the need for better 
public health care plan strategies in order to promote the early diagnosis of lesions in the oral 
cavity and oropharynx to improve patient survival rates and quality of life, with the use of less 
radical and debilitating treatments. Besides, the geographical barriers and logistical difficulties 
restrain patient access to treatment. 
 
Keywords: epidemiology, oral health, oral diagnosis, squamous cell carcinoma, salivary glands. 
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INTRODUÇÃO 
 
A epidemiologia define-se como estudo da distribuição e dos determinantes das doenças 
em populações humanas (Czeresnia & Ribeiro, 2000). Os estudos epidemiológicos mostram-se 
valiosos na reafirmação de tendências previamente estabelecidas e/ou na identificação de novos 
padrões de uma determinada doença (Gomes, 2004). A importância de estudos epidemiológicos é 
contemplada pela Lei dentro do Sistema Único de Saúde (Lei 8080, de 19 de Setembro de 1990), 
a fim de se planejar e executar programas de saúde para a população. Esses estudos devem ser 
desenvolvidos nas suas diversas regiões, já que as diferenças socioeconômicas, culturais e 
climáticas observadas apontam para uma possível distinção na prevalência dessas lesões 
(Volkweis et al., 2010). 
As lesões na cavidade bucal são comumente encontradas na prática clínica. O seu 
diagnóstico e tratamento são partes integrantes do processo de recuperação da saúde bucal (Patel 
et al., 2011) e devem ser estudadas em todas as faixas etárias para uma melhor compreensão 
(Mandali et al., 2010; Shulman, 2005). 
 Estudos epidemiológicos são conduzidos para verificar a prevalência de determinadas 
alterações clínicas na mucosa bucal (Kniest et al., 2010; Shulman et al., 2004), onde encontramos 
trabalhos que tratam de lesões específicas ou de grupos fechados de estudo (Buchner et al., 2010; 
An et al., 2008; Santos, 2002) e outros que documentam a prevalência das lesões diagnosticadas 
histopatologicamente que afetam o complexo bucomaxilofacial (Kovac-Kavcic e Skaleric, 2000; 
Deboni et al., 2005). Contudo, condições específicas podem variar entre grupos selecionados 
dentro de uma população, resultante de fatores como a idade, gênero e etnia. Inferências gerais de 
estudos populacionais podem, muitas vezes, ser aplicadas a uma população geral (Jones e 
Franklin, 2006). A epidemiologia das lesões bucais na população adulta de países em 
desenvolvimento é praticamente desconhecida devido a ausência de grandes pesquisas de base 
populacional (Carrard et al., 2011). Na região Norte do Brasil as informações sobre a prevalência 
dessas lesões na população são escassas. Apenas um trabalho foi encontrado em pacientes com 
doenças sexualmente transmitidas (An et al., 2008). 
 Jones e Franklin (2006) realizaram um estudo de 30 anos na Inglaterra onde analisaram 
44.000 lesões histologicamente diagnosticadas. Dessas lesões a maioria era benigna e 5.4% eram 
neoplasias malignas, estando de acordo com outros estudos (Carrard et al., 2011; Patel et al., 
 2 
2011). O Brasil tem a maior prevalência de câncer bucal na America Latina (Losi-Guembarovski 
et al., 2009). Quando estudamos a região de cabeça e pescoço, o carcinoma de células escamosas 
tem alta taxa de prevalência, sendo que na cavidade bucal é o mais prevalente (Scully e Bagan, 
2009). Sendo assim o conhecimento do seu comportamento em determinada localização 
anatômica pode auxiliar no diagnóstico precoce e minimizar as possíveis sequelas. 
 Os tumores de glândulas salivares são incomuns e somam menos de 6% de todas as 
neoplasias na região de cabeça e pescoço. Por não serem comuns, sua epidemiologia não está 
adequadamente descrita (Pinkston e Cole, 1999; Zini et al., 2010) em algumas regiões do Brasil 
e, ainda, os estudos mostram que variações geográficas influenciam na prevalência dos tumores 
(Oliveira et al., 2009). Na região Norte não existem estudos nessa área.  
 O objetivo geral desse trabalho foi realizar um estudo retrospectivo através da revisão de 
prontuários dos pacientes atendidos no serviço de Cabeça e Pescoço e de Odontologia na 
Fundação Centro de Controle de Oncologia do Estado do Amazonas (FCECON) de 1998 a 2009 
e analisar as características clínico-demográficas desses pacientes. Os objetivos específicos foram 
analisar as doenças malignas e benignas que acometem a cavidade bucal, dentre elas em destaque 
o carcinoma de células escamosas e os tumores de glândulas salivares. 
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CAPÍTULO 1 
Oral lesions prevalence: A twelve-year (1998-2009) study performed at FCECON in Manaus - 
Amazonas  
 
Objective: Characterize the patients attended at the Departments of Head and Neck and 
Odontology of the Oncology Center Control Foundation of the Amazonas (FCECON).  
Study design and setting: Five hundred and eighteen patient medical records were selected, using 
as the inclusion criterion the presence of oral lesions and the exclusion criteria was the lack of 
data in medical records and incapacity in confirming the histopathological diagnosis. Data 
regarding patient age, gender, race, diagnosis and tumor location were collected.  
Results: The data revealed that the majority of patients were males from European-Amerindians 
descendents, at mean age of 47.8 years and the malignant tumors were more common than benign 
ones.  
Conclusion: The large race variety of the Brazilian population make the analysis on a national 
level very difficult, but the data collected can contribute for the improvement of the health care 
planning in Northern Brazil.  
 
Introduction 
Diagnosis methods of oral lesions frequently include complementary exams such as the 
radiological, laboratorial and histological study. With reference to histological exams, biopsy 
consists in removing a fragment of a patient’s tissue for macro and microscopical study, which 
combined to the clinical and radiographic signs, allow the dental surgeon to give a final diagnosis 
to the patient.  
 Although the biopsy is the most recommended procedure to provide diagnosis for the 
majority of the orofacial lesions, its use is relatively low
1
. In addition, only a few studies have 
documented the range of histologically diagnosed lesions that affect the maxillofacial complex. 
Most studies on the prevalence of disease are epidemiological in nature and so specific conditions 
may vary among selected groups. Data like age, gender, race and others can often be applied to 
the general population
2
. These data are important because they could help the professionals in the 
development of diagnostic hypotheses, providing them with data on the prevalence of disorders 
and diseases, making it possible to estimate its frequency in their clinical practice
3
. 
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 Oral health is an important part of the quality of life and oral lesions can cause discomfort 
or pain interfering with mastication, swallowing and speech. These factors can interfere with 
daily social activities
4
. Stomatology is an important field in health caring because the oral cavity 
is the site where malignant or benign neoplastic conditions may occur
5
. Oral cancer is considered 
a public health issue, because its worldwide incidence continues to increase
6
 and also because of 
its high incidence and mortality rates.  Some regions in Asia and on Indian subcontinent, oral 
cancer remains one the most common form of cancer
7
. In Brazil, among men, oral cancer is the 
5th and in females the 7th most common site for cancer occurrence (National Cancer Institute – 
INCA)
8
. In the oral cavity and pharynx cancer can be located on the lip, tongue, gingival (gums), 
floor of the mouth, soft and hard palate, tonsils, salivary glands, oropharinx, among other less 
frequent sites
9
. 
 Epidemiology of oral lesions has been described worldwide
2
 and in some regions of 
Brazil
3
, but in the Northern region these information are scarce. According to the 2010 data of 
IBGE
10
 (Brazilian Institute of Geography and Statistics), the urban population in Northern Brazil 
is represented by 23.6% white, 4.7% African descendent, 71.2% mixed race called ―pardo‖ and 
0.4% Amerindians. In the State of Amazonas the ―pardo‖ people are the most numerous, 
representing 70% of the population. Among the ―pardo‖ people, the most common are the 
―caboclo‖, who were originated from the miscigenation between Ameridians and Europeans 
since the 19
th
 century. 
 The geographical barriers and logistical difficulties in the Amazonas restrain patient 
access to treatment which, in many cases, means that they have to travel by boat for many days to 
reach treatment centers. Thus, in cases where accessibility to treatment centers is difficult, 
efficient oral cancer prevention programs are the only alternative to alleviate patient suffering and 
to reduce morbidity and mortality rates
11
. 
 The present study is a retrospective study of oral lesions diagnosed from the Departments 
of Head and Neck and Odontology of the Oncology Center Control Foundation of the Amazonas 
(FCECON) located in Manaus, Amazonas, Northern Brazil. The survey included patient records 
from January 1998 to December 2009 and aimed to characterize the biopsied patients from this 
region of Brazil. 
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 Material and Methods 
 This retrospective study was approved by the Research Ethics Committee of Amazonas 
State University (protocol number 143/09). The medical records of patients treated at the 
Departments of Head and Neck and Odontology of the Oncology Center Control Foundation of 
the Amazonas (FCECON) located in Manaus, State of Amazonas, from January 1998 to 
December 2009 were retrieved. FCECON is the only public hospital for cancer treatment in the 
State of Amazonas, where the population is over three million people and is also the referral 
hospital for cancer treatment in the Northern region of Brazil. 
Information concerning age at diagnosis, gender, race, histopathological exam, as well as, 
tumor location were obtained from the patient records. All cases of oral and pharyngeal cancer 
treated at FCECON were evaluated and the data tabulated and analyzed. The inclusion criterion 
was the presence of oral and pharyngeal lesions. The exclusion criteria were the lack of data in 
medical records and incapacity in confirming the histopathological diagnosis. Five hundred 
eighteen medical records were selected and the data were organized in subcategories as presented 
in the results.  
The data were analyzed by using Microsoft Office Excel (Microsoft Excel for Windows, 
release 11.0, 2003, Microsoft Corporation, Redmond, WA, USA) and all statistical analysis was 
done using the software Statistica 5.1 version (StatSoft Inc., Tulsa, USA) applied Fisher’s exact 
test or the chi-square test, p value 0.05. 
 
Results 
During the 12-year period, 518 (9.9%) medical records were retrieved for analysis, where 
57.7% were males and 42.3% were females (M:F = 1.4:1). The mean age at presentation were 
49.3 and 45.8 years for males and females, respectively, within a general age range of 0 to 92 
years. Thirty-nine patients (7.5%) were children between the age 0 and 16 years. The race 
distribution was 82.2% European-Amerindians descents, 14.9% white, 2.5% Afro-Brazilian and 
0.4% Amerindians. 
A total of 73 different diagnosis were analyzed, where 276 (53.3%) were malignant, 93 
(18.0%) were benign tumors, followed by 52 (10.0%) cases of non-neoplastic proliferative 
lesions and gingival pathology (Table 1). Malignant tumors were more common among males 
(70.3%) while benign tumors in females were more common (57.0%). 
 6 
Lesions were found on all parts of the oral region, but the tongue and parotid were the 
most commonly affected. In the case of malignant tumors, a higher percentage of two or more 
site tumors were observed (12.0%) (Table 2). 
Squamous cell carcinoma was the most frequent malignant tumor (77.9%), followed by 
gland salivary tumors, the adenoid cystic carcinoma (5.4%) and mucoepidermoid carcinoma 
(4.0%). Squamous cell carcinoma was more prevalent in males while pleomorphic adenoma and 
adenocarcinoma were more common in females.  Only a case of carcinoma in situ was found in 
this study and 4 (1.4%) cases of a rare oral melanoma were found (Table 3). Mean age of patients 
with malignant tumors was 50.7 years.   
Amongst benign tumors, pleomorfic adenoma (52.7%) and focal fibrous hyperplasia 
(16.1%) were more common, some uncommon tumors like haemangiopericytoma (1.1%) and 
meningioma (1.1%) were also found (Table 4).  The mean of age of these patients was 36.4 years. 
Non-neoplastic proliferative lesions and gingival pathology showed female:male ratio 3:1 
and  pyogenic granuloma (48.1%) and fibrous epulis (46.2%) were the most frequent (Table 5 in 
Appendix 2). In the case of salivary gland pathologies (excluding neoplasia), sialadenitis was the 
most frequent (29.6%) followed by ranula (18.5%) and mucocele (14.8%). If the ranula and 
mucocele are considered a unique entity they become the most frequent.  (Table 6 in Appendix 
3). 
In this study, ossifying fibroma (41.2%) and capillary haemangioma (55.6%) affected 
more bone and connective tissues, respectively (Table 7 in Appendix 4). The odontogenic 
tumors, ameloblastoma (43.8%) and keratocystic odontogenic tumor (25.0%) were the most 
common, as well as dentigerous cyst (71.4%) that was the most common amongst odontogenic 
cysts (Table 8 in Appendix 5). Patients with odontogenic tumors and odontogenic cysts presented 
same mean age (33.1 years old).  
Leucoplakia (29.4%) and epithelial hyperplasia (23.5%) were the most frequent pathology 
observed in the mucosa (Table 9 in Appendix 6). Others pathologies less common are presented 
in Table 10  (Appendix 7). 
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Discussion 
 
 Worldwide published information on the prevalence of maxillofacial pathologies is 
scarce
2,4,5
 and a similar situation is found in Brazil. These studies are important for monitoring 
the disease incidence within a population and for future planning and implementing preventive 
and therapeutic health care services
12
.  
Many patient medical records were disconsidered in the present study because of the 
occurrence of some pathology exclusively at the neck and also because many medical records 
were incomplete. 
Recent studies have revealed that benign tumors and lesions were prevalent when 
compared to malignant tumors
2,12,13,14
. In this study malignant tumors were more frequent than 
benign ones
5
. The opposite pattern found in the present study is probably associated to the fact 
that the FCECON is the referral hospital for cancer treatment in Northern Brazil and many 
patients are screened in other medical facilities beforehand and mainly the patients with 
malignant tumors are forwarded to be treated at that hospital. On the other hand, most of the 
studies are normally performed in oral pathology centers that attend patients in general, without 
prior triage. In our sampling females account for 56.9% of all benign tumors and the mean-age of 
the patients was lower than for the group with malignant tumors (36.4 vs. 50.7 years) and these 
data were in accordance to the other studies
2
. 
 The State of Amazonas presented, in 2010, a population of 3,480,397, distributed in 
1,751,328 males and 1,729,609 females (IBGE, 2011)
15
. The male/female ratio in this study was 
1.4:1. This observation was in contrast to the data reported by Jones and Franklin (2006)
2
 and 
Patel et al (2011)
12
. They related male/female ratio 0.9:1 and 0.74:1, respectively, according to a 
study performed with individuals aged 60 years or above
16
. In some studies tumors are mainly 
found in the age group of 50 to 59 years
12
. These data are not in accordance to those of the 
present study in which lesions were found in patients of a mean of age 47.8 years. In a study 
carried out in the United States, 9.7% of 10,030 patients between 2 and 17 years of age presented 
oral lesions
17
, while in other study with patients from 0 to 16 years, 8.2% presented oral lesions
18
, 
which were slightly higher than of the present study (7.5%). Although the prevalence of oral 
mucosal disease has been found to be higher in older subjects, age is not considered to be the 
only factor correlated with oral mucosal disorders
19
. This race distribution is in accordance to the 
data presented by IBGE (2010)
10
. 
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 Tongue followed by parotid was the site most commonly affected by lesions, 
corresponding together for 30.3% of the cases. Shulman et al (2004)
20
 after examined 17,235 
adults, found that most of the lesions were in the hard palate, but other research referred that 
tongue is the most common site for intraoral cancer
21
 among European and US populations
7,22
.  
Jones et al (2006)
2
 discussed that their study was limited to patients who were 17 years and over; 
therefore, direct comparisons with previous reports are difficult. Most studies are rather limited to 
specific population groups. 
Carcinomas represent 98.1% of oral and head and neck cancers, with nearly 87% 
specifically diagnosed as squamous cell carcinoma
6
. This was also the most frequent histological 
type of malignant diseases in the present study, representing 77.9% of the malignant cases and 
this finding is in accordance to other studies
2,23,24
. In the majority of the published information, as 
well as the results observed in this study, carcinoma has been diagnosed in patients older than 50 
years old
25,26,27,28
 . Patient mean age diagnosed with squamous cell carcinoma in this study was 
63.7 years.  
Although a high percentage of oral cancer was observed in this study, apparently they had 
a weak relationship with leukoplakia
29
 because of its low occurrence, considering that only five 
patients (n= 518, 0.96%) presented leucoplakia. According to Zhang et al. (2010)
30
 the incidence 
of leukoplakia was 9.18% in a study carried out in China, but other surveys showed a frequency 
of 1.46% to 15.56%.  
The second most frequent type of malignant diseases was the adenoid cystic carcinoma, a 
salivary gland tumor that accounted for 5.4% of our cases. The predominance of adenoid cystic 
carcinoma observered in the patients of the present study has also been reported
31,32,33,34
, but 
many studies also reported mucoepidermoid carcinoma as being the most common type of 
malignant salivary gland tumor
35,36,37
 . Jones & Franklin (2006a)
1
 found similar values to 
mucoepidermoid (10.4%) and to adenoid cystic carcinoma (9.9%) and Ajavi et al (2007)
24
, in a 
study performed in Nigeria, found the adenocarcinoma as the second most common pathology of 
malignant diseases.  
While some studies pointed females as the most affected gender
33,38
, in our study the 
adenoid cystic carcinoma was more frequent in males
23
 and the mean age of 50.7 years was 
compatible with the findings of Vargas et al (2002)
38
 but a slightly high when compared with the 
data from Eveson and Cawson (1985)
33
.  
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Head and neck sarcomas are very infrequent and generally account for 5 to 15% of all 
adult sarcoma cases
39
. In a study carried out in China, its frequency was 8.77%
40
 while in another 
study done in Nigeria, the occurrence rate was 18%
24
. In the present survey, this type of cancer 
accounted for only 2.8% of all malignant neoplasm found (one case), a much lower rate than 
those found in other studies. A different aspect observed in the present study was that the patient 
was a 13-year old female, while analyzing a 10-year period of head and neck sarcoma 
occurrence, Mücke et al (2010)
41
 found that males were more affected and mean age was 49.4 
years for males and 46.4 years for females.   
Han et al (2010)
40
 found 5.92% of lymphomas, a high percentage compared to 2.1% in 
the present study. All cases of this study were only non-Hodgkin lymphomas, in agreement with 
other studies in which this type of lesion was the most common lymphoma
2,23,24
. 
Malignant melanoma is rare in the oral cavity and accounted for only 0.2 to 8% of all 
melanomas
42
. In our study there were four cases of this pathology, accounting for 1.4% of all 
malignant diseases. This value is consistent with the date from other studies
23,24
, but ethinicity is 
indicated to influence its prevalence
43
. According to Mendenhall et al (2005)
44
, the mean age of 
patients was 60 years with a male preponderance, which was confirmed by our findings.  
In general, malignancies affected more male patients (70.2%) older than 50 years of age. 
This date is in agreement with those of Chidzonga (2006)
23
, Jones & Franklin (2006)
2
 and Ajayi 
et al. (2007)
24
. Benign to malignant tumor ratio in our study was almost 1:3, a much larger 
prevalence of malignancies than found in literature, as Jones and Franklin (2006)
2
  found a 1:1 
ratio. 
In case of benign tumors, pleomorfic adenoma was the most common benign neoplasm 
(52.7%), followed by focal fibrous hyperplasia (16.1%) and squamous papilloma (6.5%). The 
present study showed differences when compared to Jones and Franklin (2006)
2
 findings, in 
which papilloma was the most frequently, followed by pleomorfic adenoma and focal fibrous 
hyperplasia.  
Most common periodontal and gingival pathologies were pyogenic granuloma (48.1%) 
and fibrous epulis (46.2%) as shown in other studies and females were more affected in all 
studies
2,16,44,45
. The higher incidence of fibrous epulis in females is probably due to their more 
frequent and longer use of complete dentures compared to men
44
. The prevalent age distribution 
for both type of lesions was 34 to 44 years in the present study. Buchner et al (2010)
45
 found the 
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highest occurrence of pyogenic granuloma in the same age range, while other studies showed the 
greatest incidence of fibrous epulis in patients older than  60 years
16
. 
The analysis of salivary gland pathologies in this study, excluding neoplasias, indicates a 
major incidence of sialodenitis (29.6%) followed by ranula (18.5%) and mucocele (14.8%), 
which was in accordance with the results of Jones et al (2006)
2
. In the present study, mean age of 
patients with sialodenite was 37.1 years, while Jones et al. (2006)
2
 found 49.7 years during a 
study carried out in England. In relation to mucocele, many studies indicated its predilection to 
children and young adults
46
, which was confirmed by our findings (mean age of 15.5 years), but 
Kovac-Kavcic and Skaleric (2000)
13
 found a major incidence in patients of 65 to 75 years of age 
in a study performed in Slovenia. 
 Ossifying fibroma (41.2%) was the most prevalent in this study while in other study its 
prevalence was 2.9%
2
. According to Ribeiro et al. (2010)
47
, this type of lesion is mainly 
diagnosed in patients between the second and fourth decade of life, which is in accordance to our 
findings, in which patients mean age was 26.0 years. Oral vascular lesions are uncommon on the 
oral mucosa and the jaws
48
, but the haemangiomas were the most frequently found in this study, 
in accordance with previous study carried out in United Kingdom
2
. 
 In this study odontogenic tumors and cysts presented equal male to female ratio. 
Odontogenic tumors in females are more common in the second and third decade of life
49,50
, but 
our findings differed on gender. Reports on the incidence of odontogenic tumors are not 
frequent
49
. The ameloblastoma was also the most frequent in this study
2,50
 but Santos et al 
(2001)
49
 found odontoma as the most common. Our findings showed that dentigerous cyst 
accounted for 71.4% and patient mean age was 25.2 years. These data are in accordance with 
another odontogenic cysts study performed in Brazil, being only the male:female (1.7:1) ratio 
different
51
. The low occurrence of cists and odontogenic tumors in this survey may be biased 
because FCECON is a referral hospital for the treatment of malignant neoplasias. 
 
Conclusion 
 The results of the present study provide information on the prevalence of oral lesions in 
Manaus – Amazonas population and it should be of interest to health care professionals. These 
results do not represent the actual prevalence within the national general population, and is 
restricted to the incidence in the Northern region of Brazil. The wide racial variance within Brazil 
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and even within the Northern region makes the interpretation of the results difficult since some of 
the lesions are directly related to the ethnical characteristic of the population. Studies that 
evaluate the prevalence of diseases are much important for health care planning in order to set 
prevention programs, early diagnosis and treatment for the improvement of health conditions of 
the population. 
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Table 1 – Distribution of patients treated at FCECON by diagnostic category and gender  (1998-
2009 period). 
 
Diagnostic category 
M F 
p 
M+F 
n % n % n % 
Malignant disease 194 65.3 82 37.1 <0.001* 276 53.3 
Benign tumors  40 13.5 53 24.0 0.002 * 93 18.0 
Non-neoplastic 
proliferative lesions and 
gingival pathology 
13 4.4 39 17.6 <0.001 * 52 10.0 
Salivary Gland 
pathology excluding 
neoplasia 
15 5.1 12 5.4 0.847 ns 27 5.2 
Mucosal and skin 
pathology 
8 2.7 9 4.1 0.384 ns 17 3.3 
Bone pathology 10 3.4 7 3.2 0.900 ns 17 3.3 
Odontogenic tumours 8 2.7 8 3.6 0.547 ns 16 3.1 
Connective tissue 
pathology 
2 0.7 7 3.2 0.032 * 9 1.7 
Odontogenic cysts 4 1.3 3 1.4 0.992 ns 7 1.4 
Miscellaneous pathology 3 1.0 0 0.0 0.134 ns 3 0.6 
Non-odontogenic cyst 0 0.0 1 0.5 0.246 ns 1 0.2 
TOTAL 297 100.0 221 100.0   518 100.0 
* – statistically significant difference between the gender (p<0.05) 
ns – no statistically significant difference between the gender 
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Table 2 – Distribution of patients treated at FCECON by lesion site 
(1998-2009 period). 
 
Site n % 
Tongue 92 17.8 
Parotid 65 12.5 
Two or more sites 62 12.0 
Gingiva 57 11.0 
Hard or soft palate 51 9.8 
Floor of the mouth 45 8.7 
Buccal mucosa 32 6.2 
Mandible 26 5.0 
Submandibular gland 24 4.6 
Lip 22 4.2 
Maxila 17 3.3 
Oropharinx or tonsils 8 1.5 
Submental or submandibular 8 1.5 
Vestibular fornix 5 1.1 
Retromolar área 4 0.8 
TOTAL 518 100.0 
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Table 3 – Distribution of patients treated at FCECON by malignant disease and gender  (1998-
2009 period). 
 
Diagnostic category 
M F 
p 
M+F 
n % n % n % mean age 
Squamous cell carcinoma 162 83.5 53 64.6 <0.001 * 215 77.9 60.6 
Adenoid cystic carcinoma 10 5.2 5 6.1 0.752 ns 15 5.4 50.7 
Mucoepidermoid carcinoma 7 3.6 4 4.9 0.622 ns 11 4.0 42.7 
Non-Hodgkin’s lymphoma 4 2.1 2 2.4 0.844 ns 6 2.2 46.7 
Melanoma 3 1.5 1 1.2 0.836 ns 4 1.4 53.5 
Carcinoma ex-pleomorphic adenoma 0 0.0 4 4.9 0.002 * 4 1.4 54.0 
Metastatic carcinoma 0 0.0 3 3.7 0.007 * 3 1.1 48.3 
Carcinoma - Undifferentiated 3 1.5 0 0.0 0.258 ns 3 1.1 49.3 
Plasmocytoma 0 0.0 2 2.4 0.029 2 0.7 68.5 
Acinic cell carcinoma 2 1.0 0 0.0 0.356 ns 2 0.7 66.0 
Adenocarcinoma 0 0.0 2 2.4 0.029 * 2 0.7 56.0 
Rhabdomyosarcoma 1 0.5 1 1.2 0.529 ns 2 0.7 24.5 
Angiosarcoma 1 0.5 0 0.0 0.515 ns 1 0.4 64.0 
Malignant Langerhans cell 
histiocytosis 
0 0.0 1 1.2 0.123 ns 1 0.4 45.0 
Malignant disease - undifferentiated 0 0.0 1 1.2 0.123 ns 1 0.4 69.0 
Osteosarcoma 1 0.5 0 0.0 0.515 ns 1 0.4 31.0 
Sarcoma 0 0.0 1 1.2 0.123 ns 1 0.4 13.0 
Carcinoma in situ 0 0.0 1 1.2 0.123 ns 1 0.4 52.0 
Myoepithelial carcinoma 0 0.0 1 1.2 0.123 ns 1 0.4 65.0 
TOTAL 194 100.0 82 100.0   276 100.0 50.7 
* – statistically significant difference between the gender (p<0.05) 
ns – no statistically significant difference between the gender 
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Table - 4 Distribution of patients treated at FCECON by benign tumor and gender (1998-2009 
period). 
 
Diagnosis 
M F 
p 
M+F 
n % n % n % mean age 
Pleomorphic adenoma 19 47.5 30 56.6 0.409 ns 49 52.7 36.8 
Focal fibrous 
hyperplasia 
7 17.5 8 15.1 0.755 ns 15 16.1 43.1 
Squamous papillomas 2 5.0 4 7.5 0.621 ns 6 6.5 37.0 
Lymphangioma 3 7.5 1 1.9 0.187 ns 4 4.3 17.0 
Warthin tumor 
(adenolymphoma) 
4 10.0 0 0.0 0.031 * 4 4.3 53.8 
Fibrous histiocytoma 1 2.5 2 3.8 1.000 ns 3 3.2 47.0 
Lipoma 1 2.5 2 3.8 1.000 ns 3 3.2 56.3 
Fibrolipoma 1 2.5 1 1.9 1.000 ns 2 2.2 37.0 
Basal cell adenoma 1 2.5 1 1.9 1.000 ns 2 2.2 56.0 
Haemangiopericytoma 0 0.0 1 1.9 1.000 ns 1 1.1 20.0 
Meningioma 1 2.5 0 0.0 1.000 ns 1 1.1 20.0 
Neurofibroma 0 0.0 1 1.9 1.000 ns 1 1.1 46.0 
Melanotic 
neuroectodermal tumor 
of infancy 
0 0.0 1 1.9 1.000 ns 1 1.1 0.0 
Myoepithelioma 
(myoepitelial adenoma) 
0 0.0 1 1.9 1.000 ns 1 1.1 40.0 
TOTAL 40 100.0 53 100.0   93 100.0 36.4 
* – statistically significant difference between the gender (p<0.05) 
ns – no statistically significant difference between the gender 
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CAPÍTULO 2 
Oral Squamous cell carcinoma: the patient’s profile in Manaus - Amazonas, Brazil  
 
Abstract 
The incidence of oral squamous cell carcinoma in Northern Brazil still remains scarce, 
mainly in Manaus – Amazonas where oral cancer is the fifth most common site among men and 
the seventh most common among women. The medical records of patients treated at the 
Departments of Head and Neck and Odontology of the Oncology Center Control Foundation of 
the Amazonas (FCECON) from January 1998 to December 2009 were retrieved and analyzed. 
Patient information such as age, gender, race, birthplace, city of residence, habits, the tumor 
location and treatment were obtained. Males were more affected than females (3.1:1). The mean 
age of the patients diagnosed was 60.6 years and tongue was the most affected site. The majority 
of patients did not consume tobacco or alcohol and received radiotherapy, radiotherapy associate 
with chemotherapy or surgery during treatment. Twenty per cent of the patients had two or more 
sites on their initial diagnosis. This may indicate the deficiency of the health caring professionals 
in the Amazonas in early diagnosing the disease, which reinforce the need to improve public 
health planning in order to improve patient survival rates and quality of life, with the use of less 
radical and debilitating treatments. 
 
Introduction 
The first written medical documents with reference to cancer are the Edwin Smith 
Papyrus (1600 B.C.) and the Ebers Papyrus (1550 B.C.). In 460 B.C., Hippocrates was the first to 
use the term carcinoma
1
. Nowadays cancer is one of the most common causes of morbidity and 
mortality, with more than 10 million new cases and more than 6 million deaths worldwide every 
year 
2
. More than 20 million people around the world live with a diagnosis of cancer and more 
than a half all cancer cases occur in the developing countries. Cancer is responsible for about 
20% of all deaths in high income countries and 10% in low income countries. It is projected that 
by 2020 there will be every year 15 million new cases of cancer and 10 million deaths caused by 
this disease
3
.  
The majority of cancer in the head and neck is the squamous cell carcinoma and the oral 
squamous cell carcinoma is the most common among them
4,5,6
. Oral cancer is a serious and 
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growing problem in many parts of the globe. Oral and pharyngeal cancer, as a group, is the sixth 
most common type of cancer in the world
7
 and the oral cancer is a malignant tumor that occurs in 
different locations in the oral cavity
8
. 
Oral lesions can cause discomfort or pain interfering with mastication, swallowing and 
speech, while symptoms such as halitosis, xerostomia or oral dysaesthesia can interfere with daily 
social activities diminishing patient’s quality of life9. The etiology of oral cancer is multifactorial 
and factors such as the use of tobacco and excess consumption of alcohol act separately or 
synergistically
7
. 
The etiology of malignancies in general is considered to be multifactorial
10
. Uses of 
tobacco and alcohol consumption
6
 are among the various risk factors for oral squamous cell 
carcinoma occurrence. Hashibe et al (2007)
11
 confirmed previous findings that cigarette smoking 
is a strong risk factor for head and neck cancer. 
According to the 2010 data of IBGE
12
 (Brazilian Institute of Geography and Statistics), 
the urban population in Northern Brazil is represented by 23.6% white, 4.7% African descendent, 
71.2% mixed race called ―pardo‖ and 0.4% Amerindians. In the State of Amazonas the ―pardo‖ 
people are the most numerous, representing 70% of the population. Among the ―pardo‖ people, 
the most common is the ―caboclo‖, who were originated from the miscigenation between 
Amerindians and Europeans since the 19th century. Brazil presents the highest incidence of oral 
cancer in Latin America
13
. According to the National Cancer Institute – INCA14 (2008), oral 
cancer is the fifth most common among men and the seventh most common among women in the 
Amazonas State and also in Brazil.  
Moore et al (2000)
15
 reported that Brazil had the highest rate of mouth cancer in the 
world. There are innumerous epidemiologic studies on oral cancer throughout the world, even in 
Brazil, but in Northern Brazil these data are scarce
16
, mainly in the Amazonas State. The present 
study is a retrospective study of oral squamous cell carcinoma cases from FCECON located in 
Manaus, Amazonas, and aimed to build the profile of oral squamous cell carcinoma patients. 
 
Material and Methods 
The medical records of all patients treated at the Department of Head and Neck and 
Odontology of the Oncology Center Control Foundation of the Amazonas (FCECON) from 
January 1998 to December 2009 were retrieved and 215 cases of oral squamous cell carcinoma 
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were analyzed. Basic patient information such as age, gender, race, birthplace, city of residence, 
habits, the tumor location, as well as, treatment were obtained. The exclusion criteria were lack of 
data in medical records and impossibility to verify the histopathology exam of the patients. The 
race distribution of the present study was done according to the IBGE
12
 as white, African 
descendents, Amerindians and European-Amerindian descendents.  
Oral cavity sites were defined as oral mucosa (C00.3,4/C06.0-C06.2)
16
, gingiva or 
alveolar ridge (C03.0-C03.1)
16
, hard palate (C05.0)
16
, tongue (C02.0,1-C02.2)
16
 and floor of the 
mouth (C04)
16
, but in this study we divided in: tongue, gingiva or alveolar ridge, floor of the 
mouth, palate, buccal mucosa, retromolar area, lip and other sites. The term ―lip‖ was used when 
referring to lesions of the upper and lower lip and lesions affecting the vermilion border, and the 
term ―tongue‖ was used to indicate lesions located in all regions of the tongue. The term ―two or 
more sites‖ was used for lesions that involved multiple anatomical sites in the oral cavity. The 
term ―other sites‖ was applied for the other regions of the oral cavity and oropharynx. 
The treatments applied were surgery, radiotherapy, chemotherapy, surgery and adjuvant 
radiotherapy, radiotherapy and chemotherapy, surgery plus adjuvant chemotherapy, surgery plus 
adjuvant radio and chemotherapy. When patients were not able to undergo one of the treatments 
presented above, ―no treatment‖ was noted. 
 The data were analyzed by using Microsoft Office Excel (Microsoft Excel for Windows, 
release 11.0, 2003, Microsoft Corporation, Redmond, WA, USA) and all statistical analysis was 
done using the software Statistica 5.1 version (StatSoft Inc., Tulsa, USA) applied Fisher’s exact 
test or the qui-square test, p value 5%. 
The present study was performed in accordance to the Research Ethics Committee – 
Amazon State University, process number 143/09. 
 
Results 
Out of a total of 215 patient records, 162 were male (75.3%) with mean age of 57.4 years, 
53 were female (24.7%) with mean age of 60.6 years. The highest of occurrence for male of oral 
squamous cell carcinoma was at 41-70 years, whilst the occurrence for females were most 
frequent at 51-70 years and at 81-90 years of age (Table 1).  
The majority of the patients were European-Amerindian descendents (80%), some were 
white (16.7%) and 3.3% were African descendents.  Eighty-one patients had been living in 
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Manaus, sixty were from the country side of Amazonas and seventy-four came from other States.  
Among these last, third-three patients were living in Manaus and forty-one were coming to 
Manaus only for treatment. European-Amerindian descendents accounted for 172 and were the 
most affected (80%) followed by the white 36 (16.74%) and only 7 (3.26%) were African 
descendents.
 
 The most frequent site of the tumor was the tongue (31.6%), followed by two or more 
sites (20.9%) and the floor of the mouth (13.5%) (Table 2). Among the patients that presented 
two or more anatomical sites at the diagnosis, 33.3% were from Manaus, 31.1% from the country 
side of the State of Amazonas and 35.6% originated from other States. These patients were 
primarily treated with radiotherapy and radiotherapy associated with chemotherapy and presented 
mean age of 59.3 years and were prevalently males. 
The majority of the patients (59.1%) did not report any habits (alcohol or tobacco 
consumption). The association of these two habits was present in 20.5% of the patients, followed 
by tobacco consumption (19.1%). Only 1.9% of the patients did not report alcohol consumption 
(Table 3).  
Analyzing all cases combined, radiotherapy represented the most frequent treatment used 
(29.3%), followed by surgery (24.2%) and radiotherapy associated with chemotherapy (23.7%) 
(Table 5). However, when the data was analyzed in two different periods, radiotherapy associated 
with chemotherapy was the most common treatment, followed by surgery (Table 6). 
 
Discussion 
Many patient medical records were disconsidered in the present study because of the 
occurrence of some pathology exclusively at the neck and also because many medical records 
were incomplete. 
In this study, oral squamous cell carcinomas occurred more frequently among males than 
females. In countries considerer of high-risk, such as, Sri Lanka, India, Pakistan and Bangladesh, 
oral cancer is the most common cancer in men
7
. This greater ratio of males in the occurrence of 
oral squamous cell carcinoma was seen in innumerous studies
18,19,20,21,22,23,24,25
. However, 
Llewellyn et al (2003)
26
 observed higher oral cancer occurrence in young women than in young 
men, but in older patients (mean 58.6 years) they observed even a ratio of 6.6:1.0 male to 
female
13
.  
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In the present study, mean age of women diagnosed with oral squamous cell carcinoma 
was 60.6 years and similar values were observed in other studies
4,27
. Kruse et al (2010)
28
 reported 
male:female ratio of 46:53 to mean age of 79 years old. In this study, it was also observed an 
increase in the incidence of oral squamous cell carcinoma in women of 81 to 90 years of age. The 
frequency of oral cancer in young people is extremely low
10
. 
Some studies performed in Southern Brazil showed that white patients were the most 
affected
22,29,30,31
, but Gervásio et al (2001)
18
 showed that white patients were the least affected. 
These data can be compared with those of the Northern region of Brazil, where European-
Amerindian descendents were the most affected, as well as the Northeastern region where non-
white were the most affected
25
. Comparing the incidence of oral squamous cell carcinoma among 
races in Brazil is rather difficult due to the large miscegenation in the Brazilian population
31
. 
Marocchio et al (2003)
31
 observed that dentists are much aware of their role as health care 
professionals and they can detect oral cancer early. However, this was not the case in the present 
study, since 20% of the patients were diagnosed with cancer in two or more anatomical sites. 
This may indicate the deficiency of these professionals in the Amazonas in early diagnosing the 
disease. It is also important to consider that in the present study, several patients came from the 
country side of the Amazonas State which, in many cases, means that they had to travel by boat 
for many days to seek treatment. 
No site within the oral cavity is immune to the squamous cell carcinoma. However, 
certain sites are well recognized as locations where cancer occur more frequently
4
. Tongue is the 
most common site for intraoral cancer
17
 among European and US populations
15, 32
 and buccal 
cancer is more common among Asian populations
7
. Studies carried out in California among a 
diverse of racial and ethnical populations, tongue was the most common subsite for oral 
squamous cell carcinoma
8,33
. Llewlyn & Mitchell (1994)
34
 found the highest incidence in the 
floor of the mouth and tongue. The tongue was the most affected site (53%) followed by the 
buccal mucosa (9.5%) and maxillary gingiva (9%). However, on a study performed in Iran, the 
floor of the mouth was the least involved
23
 and in two other studies carried out in Southern Brazil 
a greater number of cases were found occurring in the gingiva
29,31
. 
Women are more likely to develop carcinoma of the gingiva (rigde included), whereas 
men have more propensity to develop cancer in the floor of the mouth
32
. Oral squamous cell 
carcinoma in floor of the mouth in this study was prevalent in males but in the gingiva gender 
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ratio was 1:1. The retromolar trigone is a relatively uncommon site for oral squamous cell 
carcinoma
35
 as observed in the present study. Epidemiological studies have shown that the sites 
of occurrence of oral cancer differ widely
18
. 
The lower lip vermilion is by far the most common site of oral cancer
18
 because this 
anatomical site usually receives a higher exposure of solar radiation
36
. Lip cancer is particularly a 
problem of older people and is a disease that affects especially males, being a common lesion of 
the lower lip in Caucasians living in hot climates
6
. In Tropical cities high incidences of lip 
squamous cell carcinoma is expected, although in this study only 6.0% was observed. The high 
miscegenation in the Amazon may have been beneficial to its population considering that 
Bertotto et al (2003)
37
 found no occurrence of lip cancer among Indians despite their constant 
exposure to the sun. 
Since 1965, the relation between alcohol and tobacco use and cancer of the mouth has 
been studied
38
. Nowadays, it is well known that smoking is a strong risk factor for head and neck 
cancer independently of alcohol consumption
11
. In some cases, alcohol consumption is the major 
risk factor to cancer
15
. Within the Europe countries, the highest incidence rates occur in males 
from France and Hungary where alcohol consumption is high, while the lowest rates are found in 
Greece and Cyprus
7
. 
According to the 2008 National Home Sample Survey (PNAD)
39
 carried out by the 
Brazilian Institute of Geography and Statistics (IBGE), the State of Amazonas presents one of the 
lowest rates of smokers in Brazil. These data are in accordance to those of the present study 
where the majority of the patients (59.1%) did not report alcohol and tobacco consumption. 
However, some individuals who had minimal levels of tobacco or alcohol use might have been 
included in the ―never used tobacco‖ and ―never drink‖11.  
Kruse et al (2010)
28
 discussed the tongue and floor of mouth sensitivity to the 
carcinogenic effects of tobacco or alcohol. In this study, no correlation was found between the 
anatomical sites and the patient habits to consume alcohol or tobacco. 
Despite the low rate of tobacco users in this study, the incidence of oral cancer was 
similar to those of other States in Brazil
14
. In a study carried out in the United States, a significant 
portion of the patients with oral cancer reported no history of smoking
40
, thus the etiology of oral 
squamous cell carcinoma on those who never smoked is still unclear
28
. Llewellyn et al (2003)
26
 
reported in their study that one quarter of all cases had no major risk factors associated, such as, 
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the exposure to tobacco or excessive levels of alcohol, and 6% of these had never smoked or 
drunk alcohol regularity. The incidence of cancer of the head and neck varies throughout the 
world and the etiology has been described to local carcinogenesis that produces this variation
34
. 
Surgery remains the most well established definitive treatment at first for the majority of 
patients with oral squamous cell carcinoma
41
. Radiotherapy can be used on early-stages and 
locally in advanced disease, alone or combined with surgery and/or chemotherapy
42
. Also, 
chemotherapy has been used for local treatment or as a palliative therapy
43
. In the present study, 
the most common treatment used was the radiotherapy in the period from 1998 to 2009. 
However, when analyzing the period from 2004 to 2009, the radiotherapy associated with 
chemotherapy was the most common treatment applied. The major advance in the concomitant 
treatment chemotherapy-radiotherapy has been improving the treatment in locally advanced 
cases
42,43
. 
Our results were similar to those of patients in Northeastern of Brazil, except for the fact 
that in the present study the patients had the lowest rate of lip cancer and the consumption of 
tobacco and alcohol were lower than in other regions. 
Cancer registries are part of a surveillance system. Efforts to prevent and control cancer 
are hampered by the low priority frequently given by governments. The excessive expenditure on 
treatments and the considerable unbalance between resources allocated to basic cancer research 
and those directed to its prevention and control also contribute to the expansion of the disease. 
It is important to consider that in the present study, 81 patients had been living in Manaus, 
another 74 patients came from other States and 60 came from the countryside of the Amazonas 
State which, in many cases, meant that they traveled many days to be treated. Therefore, many 
patients looked for treatment only when the disease caused too much pain or disability to eat, 
which can also explain why some tumors had two or more sites. The Oncology Center Control 
Foundation of the Amazonas (FCECON) is a referral center in the oncology treatment in 
Northern Brazil, therefore many patients come from other States seeking for treatment. As a 
result, the follow up of the disease and results of the treatments is difficult for those patients from 
the country side and for those coming from other States. 
Conclusion 
Based on data from a 12-year period from the only Amazonas State Public Oncology 
Center, patient with oral squamous cell carcinoma in this region were most commonly man 
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(75,3%); European-Amerindian descendent (80%); with mean-age of 57.4 years; no consumer of 
alcohol or tobacco (59.1%).  These characteristics were similar to those of patients in 
Northeastern Brazil, except for the fact that in the present study the patients had the lowest rate of 
lip cancer and the consumption of tobacco and alcohol were lower than in other regions. 
The Amazon region presents geographical barriers and logistical difficulties, aggravated 
by poor and expensive transport infrastructure which restrain patient access to treatment. As a 
result, the diagnosis of pathologies may be delayed considering the lack of health care 
professionals in the countryside of the Amazonas State, indicated by 20.9% of patients that 
presented two or more sites affected by the disease. Thus, a more comprehensive health care 
planning is required compared to other regions of Brazil, where road transport is available. 
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Table 1 – Age and gender distribution of patients with squamous cell carcinoma. 
 
Age 
(year) 
F M F+M 
n % n % n % 
21-30 1 1.9 2 1.2 3 1.4 
31-40 3 5.7 9 5.6 12 5.6 
41-50 7 13.2 35 21.6 42 19.5 
51-60 12 22.6 58 35.8 70 32.6 
61-70 12 22.6 36 22.2 48 22.3 
71-80 7 13.2 16 9.9 23 10.7 
81-90 11 20.8 6 3.7 17 7.9 
Total 53 100.0 162 100.0 215 100.0 
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Table 2 – Frequency of cancer site distribution according to gender. 
 
Site 
Gender 
M F 
p 
M+F 
n % n % n % 
Tongue 54 33.3 14 26.4 0.347 ns 68 31.6 
Two or more sites 33 20.4 12 22.6 0.724 ns 45 20.9 
Palate 21 13.0 9 17.0 0.464 ns 30 14.0 
Floor of the 
mouth 
23 14.2 6 11.3 0.594 ns 29 13.5 
Lips 8 4.9 5 9.4 0.233 ns 13 6.0 
Gingiva 5 3.1 5 9.4 0.057 ns 10 4.7 
Other anatomical 
location 
10 6.2 0 0.0 0.064 ns 10 4.7 
Buccal mucosa 7 4.3 2 3.8 0.863 ns 9 4.2 
Retromolar 
trigone area 
1 0.6 0 0.0 0.566 ns 1 0.5 
TOTAL 162 100.0 53 100.0   215 100.0 
ns – no statistically significant difference between the gender 
 
 
 
Table 3 – Frequency of patient’s habits according to gender. 
 
Site 
Gender 
M F M+F 
n(%) n(%) n(%) 
Tobacco 30(18.5) 11(20.7) 41(19.1) 
Alcohol 0(0.0) 3(5.7) 3 (4.1) 
Both
a 36(22.2) 8(15.1) 44(20.5) 
No habits
b 96 (59.3) 31(58.5) 127(59.1) 
 Total 162(100.0) 53(100.0) 215(100.0) 
Tobacco and Alcohol consumptiona / No tobacco or alcohol consumptionb 
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Table 4 – Distribution of cancer site of patients by habits. 
Site Tobacco Alcohol Both Anyone 
Tongue 12 2 14 40 
Floor of the mouth 5 1 10 13 
Palate  3 0 6 21 
Gingiva  3 0 2 5 
Buccal mucosa 3 0 1 5 
Lip  4 0 1 8 
Two or more sites 9 0 8 28 
Retromolar trigone area 0 0 0 1 
Other mouth 2 0 5 3 
 Total   41 3 47 124 
P value = 0.59977 – Fisher’s exact test 
 
 
Table 5 – Distribution of treatment by gender in a 12-year period. 
 
Treatment 
M F 
p 
M+F 
n % n % n % 
Surgery 36 22.2 16 30.2 0.240 ns 52 24.2 
Radiotherapy 45 27.8 18 34.0 0.391 ns 63 29.3 
Chemotherapy 5 3.1 1 1.9 0.645 ns 6 2.8 
Surgery + adjuvant radiotherapy 12 7.4 5 9.4 0.635 ns 17 7.9 
Radiotherapy + chemotherapy 44 27.2 7 13.2 0.038 * 51 23.7 
Surgery + adjuvant chemotherapy 2 1.2 1 1.9 0.725 ns 3 1.4 
Surgery + adjuvant radio and chemotherapy 10 6.2 1 1.9 0.219 ns 11 5.1 
No treatment 8 4.9 4 7.5 0.473 ns 12 5.6 
TOTAL 162 100.0 53 100.0   215 100.0 
* – statistically significant difference between the gender (p<0.05) 
ns – no statistically significant difference between the gender 
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Table 6 – Frequency of treatments according to gender in two periods. 
 
Treatment 
1998 – 2003   2004 - 2009 
p 
F M M+F %   F M M+F % 
Surgery 5 16 21 21.2  11 20 31 26.7 0.347 ns 
Radiotherapy 8 30 38 38.4  10 15 25 21.6 0.007 * 
Chemotherapy  -    2 2 2.0  1 3 4 3.4 0.526 ns 
Surgery + adjuvante radiotherapy 3 7 10 10.1  2 5 7 6.0 0.271 ns 
Radiotherapy + chemotherapy 2 16 18 18.2  5 28 33 28.4 0.078 ns 
Surgery + adjuvante chemotherapy  -    2 2 2.0  1  -    1 0.9 0.471 ns 
Surgery + adjuvante radio and chemotherapy  -    2 2 2.0  1 8 9 7.8 0.057 ns 
No treatment 2 4 6 6.1  2 4 6 5.2 0.777 ns 
TOTAL 20 79 99 100.0   33 83 116 100.0   
* – statistically significant difference between period (p<0.05) 
ns – no statistically significant difference between period 
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CAPÍTULO 3 
Salivary Gland Tumors: A Retrospective study in Northern Brazil. 
 
BACKGROUND: The aim of this study is to present a retrospective study of salivary gland 
tumors cases in Manaus – Amazonas (Northern Brazil), over a 10-year period (1998-2009). 
METHODS: The medical records of all patients treated at the Department of Head and Neck and 
Odontology of the Oncology Center Control Foundation of the Amazonas (FCECON) were 
retrieved and data on the patient with salivary gland tumors with epithelial or mesenchymal 
origin were analyzed. 
RESULTS: Salivary gland tumors were 58.3% benign and 41.7% were malignant. For benign 
tumor, females were more affected than males, but for malignant tumors the occurrence was 
almost two times higher for males.  The average age of patients with benign tumors was 48.0 
years for males and 45.0 years for females, while for malignant tumors the average age was 54.5 
years for males and 48.6 years for females. In the group of benign tumors, the predominant type 
was pleomorphic adenoma, whilst amongst the malignancies, the adenoid cystic carcinoma was 
the most frequent. 
CONCLUSIONS: The present study showed that many clinical characteristics of salivary gland 
tumors are similar to those found elsewhere in the world and in other regions in Brazil, 
contributing for better understanding and treating the disease. 
Keywords: intra-oral neoplasm, salivary gland tumors 
 
INTRODUCTION 
 Salivary tumors are uncommon and comprise less than 6% of all neoplasms of the head 
and neck region
1,2,3
, but generate considerable interest because of their variation in histological 
and clinical presentation
4
.  Salivary gland tumors present a yearly incidence of about 1.0 to 6.5 
per 100,000 worldwide and about 2.5 to 3.0 per 100,000 in the Western world. Since 1991, the 
World Health Organization (WHO) named almost 43 epithelial tumors in salivary glands
2,5
.  
 Salivary glands are anatomical and functional adnexae of the oral cavity. Therapy of 
tumors of these glands involves various specialists but the disease is mainly treated by 
maxillofacial surgeons
6
.  The knowledge on the most current diseases is important to the 
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epidemiologists, to public health policy and to the health professionals, allowing the planning of 
specific therapeutical approaches for each disease
7
. 
 According to the 2010 data of the Brazilian Institute of Geography and Statistics (IBGE)
8
, 
the urban population in Northern Brazil is represented by 23.6% white, 4.7% African 
descendents, 71.2% mixed race called ―pardo‖ and 0.4% Amerindians. In the State of Amazonas 
―pardo‖ people are the most numerous, representing 70% of the population. Within those, the 
most common is the ―caboclo‖, who were originated from the miscegenation of Amerindians and 
Europeans since the 19
th
 century. 
 The epidemiology of salivary gland tumors has been described in some regions of Brazil
9
 
but in the Northern region these information are scarce. The present study is a retrospective study 
of salivary gland tumor cases from a single institution located in the State of Amazonas, Northern 
Brazil. 
 
MATERIAL AND METHODS 
 This retrospective study was approved by the Research Ethics Committee of Amazonas 
State University (protocol number 143/09). The medical records of all patients treated at the 
Department of Head and Neck and Odontology of the Oncology Center Control Foundation of 
the Amazonas (FCECON) from January 1998 to December 2009 were retrieved. FCECON is the 
only public hospital for cancer treatment in the state of Amazonas, which has a population of 
over three million inhabitants, and is also the referral hospital in the entire Northern region. 
Ninety-six cases of salivary gland tumors with epithelial or mesenchymal origin were analyzed. 
Information concerning age at diagnosis, gender, race, birthplace, as well as, the tumor location, 
were obtained from the patient records. Rare cases of salivary gland neoplasms were also 
analyzed. 
The criterion for inclusion in the study was the histological diagnosis of salivary gland 
tumor based on the second edition of the WHO’s Histological Classification of Salivary Gland 
Tumors
10
 and the exclusion criterion was the lack of adequate information. 
 The data were analyzed by using Microsoft Office Excel (Microsoft Excel for Windows, 
release 11.0, 2003, Microsoft Corporation, Redmond, WA, USA) and all statistical analysis was 
done using the software Statistica 5.1 version (StatSoft Inc., Tulsa, USA) applied Fisher’s exact 
test or the qui-square test, p value 5%. 
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RESULTS 
The total number of salivary gland diseases was 127. Salivary tumors accounted for 
75.6% (96) of all salivary gland diseases and for 1.83% of all neoplasm treated in this hospital. In 
this study 58.3% (56) of salivary gland tumors were benign and 41.7% (40) were malignant. The 
male:female ratio was 1:1.3 for benign tumor while for malignant tumors the ratio was almost 
two times higher for males (table1).  
The average age at diagnosis of benign tumors was 40.6 years for males and 38.2 years 
for females and for malignant tumors average age was 53.0 years for males and 45.2 years for 
females (table 2). The high incidence for patients with benign tumors was in the second and third 
decades. However, for the patients with malignant tumors the majority of incidence was in the 
fifth and sixth decade.  
Children/adolescents were the minority (7.2%) and the average age was 18.1 years, the 
youngest was 15 years old. Most of the tumors were pleomorphic adenoma (71.4%), another 
28.6% were adenoid cystic carcinoma and mucoepidermoid carcinoma both on a same 
proportion. 
In the group of benign tumors, the predominant type was pleomorphic adenoma, while 
amongst the malignancies, the adenoid cystic carcinoma (15.6%) was most frequent (table 3) and 
mucoepidermoid carcinoma was the second (11.5%). Although uncommon, one case of 
myoepithelial carcinoma was found. 
Two cases of acinic cell carcinoma were diagnosed in two 66 years old male patients, one 
located in the parotid gland and another in the floor of the mouth. Basal cell adenoma was 
detected in two patients, one of each gender; both arisen in the parotid gland. Male patient was 
55.0 years old and female was 57.0. Non Hodgkin’s lymphoma was detected in the parotid gland 
in four patients, who were all males with mean age of 43.5 years old. A case of myoepithelial 
carcinoma was diagnosed in a 65.0 years-old woman, located in the parotid gland and other 40.0 
years-old woman presented a myoepithelioma in the parotid gland. 
The parotid gland was the most common site of salivary tumors (56%), followed by the 
submandibular gland (13%) and the minor salivary gland in the palate (10%). Five patients had 
malignant tumor in two or more sites and due to their large extension, the primary sites were not 
determined. Two patients had tumor on the tongue, a pleomorphic adenoma and an adenoid 
cystic carcinoma and one patient had a mucoepidermoid carcinoma in retromolar trigone area. 
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Statistical analysis showed that pleomorphic adenoma occurred more in females than males, p = 
0.007 (table 3). 
The majority of the patients were European-Amerindian descendents, some were white 
and only one was African descendent.  Thirty five patients had been living in Manaus, 31 were 
from the country side of Amazonas and 31 came from other States.  
The benign salivary gland tumors are the most common in different regions where 
pleomorphic adenoma was the most frequent for all regions in Brazil. Among the malignant 
tumors, adenoid cystic carcinoma was the most frequent in Northern and Northeast regions. In 
the Southern and Southeast regions of Brazil, mucoepidermoid carcinoma was the most frequent 
(table 4). 
 
DISCUSSION 
Ninety six cases of salivary gland tumors were found, accounting for 1.84% of all 
neoplasms treated in this hospital. This number is consistent with the frequency often found in 
the literature
1,2,3
. There was a predominance of benign salivary gland tumors (57.1%) over 
malignant tumors. This predominance of benign tumors had been seen in other studies 
1,9,11,12,13,14
, 
but a study carried out in Thailand found 52.7% of malignant tumors while benign accounted 
47.3%
15
. It was justified by having the dental school occasionally receiving referred cases of 
malignant tumors. It was also discussed if it reflected the true incidence in their geographic 
region and their racial population or not.  
In the present study, benign tumors were more prevalent in females and patients with 
malignant tumors commonly were older and males. Greater ratio of females in the occurrence of 
benign tumors was seen in innumerous studies
1,9,11,12,15
, but Tian et al (2010)
16
 showed a slight 
propensity toward males. Other studies showed no gender predominance for both benign and 
malignant tumors
6,17,18,19
. Sun et al (1999)
20
 described that salivary gland cancer was slightly 
higher among females than males until the age range of 40-44 years, after which males were at a 
higher risk. Some differences can be attributed to race and geographical location
21
.  
In this study, the highest of incidence of benign salivary tumors was found in the second 
and third decades, the same values seen in a Chinese study
12
. However, Eveson & Cawson 
(1985)
22
 found benign salivary tumors most frequently in the sixth decade. Ito et al (2005)
9
 found 
the most frequent occurrence in patients at the fifth decade and Subhashraj (2008)
18
 found at the 
 43 
fifth and the sixth decade of life. In the case of malignant salivary gland tumors, this study found 
the prevalent incidence in the seventh decade
9,22
, but Subhashraj (2008)
18
 and Moreira et al 
(2009)
11
 found in the sixth decade the highest incidence of malignant tumors. Epithelial 
malignances of the salivary glands are not limited to a certain age. They can occur in children as 
well as in adults
19
. 
Patients with a benign tumor which occurs at a young age have higher risk of developing 
a malignant parotid carcinoma
23
. Sun et al (1999)
20
 found that the incidence of salivary gland 
cancer increased markedly with aging. They described that females until the age range of 40-44 
had a slightly higher incidence than males but after that, males were at a higher risk. In 
children/adolescents, the occurrence of salivary gland tumors is rare
24
.  
The most common site for the occurrence of tumor in this study was the parotid gland (n= 
54), followed by the minor salivary gland (n= 17) and submandibular gland (n= 13)
4,9,12,13,17,18,22
. 
Others studies showed that the majority of salivary gland tumors was the parotid gland, followed 
by submandibular gland and minor salivary gland
11,14
. Tilakaratne et al (2009)
25
 found the 
majority of the tumors occurrence in the minor salivary gland followed by parotid gland. The 
data from the statistical analysis indicated that the histological type of tumor depends on its 
location, which can explain the difference in the incidence between benign and malignant of 
certain neoplasia. When malignancies were analyzed, the most common site was the minor 
salivary glands
11,16
 and Speight & Barrett (2002)
2
 related that the majority of tumors arising from 
the minor salivary glands and sublingual gland are malignant.  
The predominant type of benign tumors in our study was pleomorphic adenoma, which is 
also listed universally as the most common tumor in other studies 
2,6,9,10,11,13,15,26,27
. The 
predominance of adenoid cystic carcinoma in the patients of the present study had been related 
6,11,22,26
, but many studies reported mucoepidermoid carcinoma as being the most common type of 
malignant tumor 
2,9,13,25,28,29
. Jones & Franklin (2006)
27
 found similar values to mucoepidermoid 
(10.4%) and to adenoid cystic carcinoma (9.9%). 
Dhanuthai et al (2009)
15
 referring to studies from USA, Brazil, Venezuela, Australia, 
Libya and China revealed that mucoepidermoid carcinoma was the most common malignant 
salivary gland tumor. However, studies from UK, the Netherlands, Japan, China and South Africa 
found the adenoid cystic carcinoma the most common. In Brazil, when analyzing malignant 
tumors, it was found a predominance of adenoid cystic carcinoma in the Northern and 
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Northeastern regions. In the Southern and Southeastern Brazil, mucoepidermoid carcinoma was 
the most common (Table III). Perhaps, this variability observed in these studies performed in 
Brazil can be explained for its differences in the racial distribution. For example, in the Northern 
and Northeastern regions the predominance race is European-Amerindian and European-African 
descendents while in Southern and Southeastern white is the predominant (IBGE, 2010)
8
. 
The results of our survey with 96 patients showed the distribution of 87.5% European-
Amerindian descendents, 12.5% white and 1.0% African descendent and were, in accordance to 
the race distribution published by IBGE (2010). Pinkston & Cole (1999)
1
 showed that incidence 
rates varied considerably by race. In opposition, the present study indicated no significant 
difference in the incidence rate by race. Other studies carried out in Brazil by Ito et al (2005)
9 
and 
Vargas et al (2005)
13
 in Southeastern and Southern Brazil, respectively, reported different 
incidence of salivary gland tumors
30 
compared to the present study.  
Some rare cases were diagnosed in this study, acinic cell carcinoma is one and two cases 
were diagnosed in two male patients. Omlie & Koutlas (2010)
31
 found that males  were more 
affected than female, but other studies showed males were the least affected
32,33
. Age range in the 
studies was 48-70 years old. This neoplasm comprises approximately 7% to 15% of all malignant 
tumors arising in salivary glands, with majority affecting the parotid gland, which was the 
location of one of the lesions. The other lesion was detected in the floor of the mouth, a rare 
location for this kind of tumor
32
.  
The real frequency of intraoral myoepithelial carcinoma remains unknown
34
.  This type of 
neoplasm represents only about 0.4 to 0.6% of all salivary gland tumors, but in a Chinese study it 
represented 3%
16
. The incidence ratio of male:female was approximately equal. The majority of 
myoepithelial carcinoma affects the major salivary gland
34
, as diagnosed in one female patient in 
our records, who presented the parotid gland affected. 
Malignant lymphomas of the oral region are rare and account for approximately 3.5% of 
all oral malignancies
35
. This incidence was confirmed in a Chinese study with 6,982 patients 
where no case of oral malignant lymphoma was found
16
. In this study, two cases were found in 
males and were located in the parotid. It represented 2.16% in our oral malignancies study. 
Basal cell adenoma accounts for 1-3% of all salivary gland tumors
36
, and in this study two 
male patients were diagnosed with this type of tumor, differently from other studies in which 
females were the most affected
37
. The basal cell adenoma is a benign neoplasm that typically 
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affects major salivary glands, in which 75% of the cases occur in the parotid gland
35
, the same 
location seen in the patients of this study.  
A case of myoepithelioma was diagnosed in the parotid gland of a female patient of the 
present study. This benign tumor is rare, accounting for less than 1% of all salivary gland tumors 
in some studies
38
 while others have shown an occurrence of 3%
11
. In most cases, this type of 
tumor affects the parotid gland, as seen in the patient in our records. Also, there is no apparent 
predilection for any gender
11
. 
It is important to consider that in the present study, 35 patients had been living in Manaus 
and 31 came from the country side of the Amazonas State which, in many cases, means that they 
had to travel by boat for many days to seek treatment. Therefore, many patients living in the 
country side look for treatment only when the disease causes too much pain or disability to eat, 
what can also explain why some tumors had two or more sites. Another 31 patients came from 
other States to be treated at the Oncology Center Control Foundation of the Amazonas 
(FCECON), which is a referral center in the oncology treatment in Northern Brazil. As a result, 
the follow up of the disease of these patients was also very difficult. 
 
CONCLUSION 
 This group of patients do not represent the whole country of Brazil, but in summary, the 
majority of the tumors were benign, found in the parotid gland and in females. Pleomorphic 
adenoma was the most frequent histological type, followed by the adenoid cystic carcinoma, 
Warthin’s tumor and mucoepidermoid carcinoma. These results showed that many clinical 
characteristics of disease are similar to those found elsewhere in the world and in other regions of 
Brazil. Salivary gland tumor distribution is indicated to be related to race and the group of 
patients on this study may represent the occurrence in Northern and Northeastern Brazil. Many 
clinical characteristics of disease found in this study are similar to those found elsewhere in the 
world and in other region of Brazil, contributing for better understanding and treating salivary 
gland tumors. 
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Table 1 - Frequency of benign and malignant tumors according to gender. 
 
Gender 
Benign Malignant 
Total 
n % n % 
Male 24 45.3 29 54.7 53 
Female 31 72.1 12 27.9 43 
Total 55 57.3 41 42.7 96 
P = 0.008* (statistically significant difference between the gender (p<0.05)) 
 
 
Table 2 - Frequency of salivary tumors according to gender and age. 
 
Tumor 
Gender Mean age 
M F 
P 
M+F (years) 
n % n % n % M  F M+F 
Benign (n = 56)           
Pleomorphic adenoma 19 38.0 30 65.2 0.007* 49 51.0 37.1 36.7 36.8 
Warthin tumor 
(adenolymphoma) 
4 8.0 0 0.0 0.118 ns 4 4.2 53.8 - 53.8 
Basal cell adenoma 1 2.0 1 2.2 1.000 ns 2 2.1 55.0 57.0 56.0 
Myoepithelioma 
(myoepitelial adenoma) 
0 0.0 1 2.2 0.479 ns 1 1.0 - 40.0 40.0 
Malignant (n = 40)                     
Adenoid cystic 
carcinoma 
10 20.0 5 10.9  0.218 ns 15 15.6 56.3 45.0 52.5 
Mucoepidermoid 
carcinoma 
7 14.0 4 8.7 0.664 ns 11 11.5 49.6 35.8 44.5 
Malignant lymphomas 4 8.0 0 0.0 0.118 ns 4 4.2 43.5 0.0 43.5 
Carcinoma ex- 
pleomorphic adenoma 
3 6.0 1 2.2 0.618 ns 4 4.2 46.7 64.0 51.0 
Acinic cell carcinoma 2 4.0 0 0.0 0.496 ns 2 2.1 66.0 - 66.0 
Adenocarcinoma 2 4.0 0 0.0 0.496 ns 2 2.1 56.0 - 56.0 
Squamous cell 
carcinoma 
1 2.0 0 0.0 1.000 ns 1 1.0 69.0 - 69.0 
Mioepithelial 
carcinoma 
0 0.0 1 2.2 0.479 ns 1 1.0 - 65.0 65.0 
TOTAL 50 100.0 46 100.0   96 100.0       
* – statistically significant difference between the gender (p<0.05) 
ns – no statistically significant difference between the gender 
87.5% 
%%% 
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Table 3 - Histological classification and site of salivary gland tumors. 
 
Tumor Parotid Submandibular Palate Buccal 
Floor of 
Lip 
Retro-molar  
Tongue 
Two or 
Total (%) 
the mouth trigone area more sites 
Benign                       
Pleomorphic adenoma 36  (73%) 9 (18%) 2 (4%)   1   (2%)  1  (2%)  49 51.0% 
Myoepithelioma (myoepitelial 
adenoma) 
1   (100%)         1 1.0% 
Basal cell adenoma 2   (100%)         2 2.1% 
Warthin tumor 
(adenolymphoma) 
3    (75%) 1 (25%)               4 4.2% 
Malignant            
Acinic cell carcinoma 1    (50%)    1 (50%)     2 2.1% 
Mucoepidermoid carcinoma 4    (36%)  3 (27%)  1  (9%)  1  (9%)  2    (18%) 11 11.5% 
Adenoid cystic carcinoma 2    (13%) 2 (13%) 3 (20%) 2 (13%) 4 (27%)   2 (13%)  15 15.6% 
Adenocarcinoma         2  (100%) 2 2.1% 
Carcinoma in pleomorphic 
adenoma 
2    (50%)  2 (50%)       4 4.2% 
Squamous cell carcinoma  1 (100%)        1 1.0% 
Malignant lymphomas 2 (50%)       1 (25%) 1    (25%) 4 4.2% 
Myoepithelial carcinoma 1  (100%)         1 1.0% 
TOTAL 54  (56%) 13 (14%) 10 (10%) 2  (2%) 6  (6%)  1  (1%) 1  (1%) 4  (4%) 5      (5%) 96 100.0 
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Table 4 – Comparison of reported distribution of salivary gland tumors in different regions in Brazil 
        Brazil  Total Years    Salivary glands Pleomorphic  Adenoid cystic Mucoepidermoid 
Region (n) Covered Benign Malignant Major Minor adenoma carcinoma carcinoma 
Southern
1 496 1972-2001 335 (67.5%) 161 (32.5%) 383 (77.2%) 113 (22.8%) 269 (54.2%) 39 (7.9%) 67 (13.5%) 
Southeastern
2 124 1993-1999 99 (79.8%) 25 (20.2%) 118 (95.2%) 6 (4.8%) 84 (67.7%) 5 (4.0%) 13 (10.5%) 
Northern
3 97 1998-2009 57 (58.8%) 40 (41.2%) 68 (70.1%) 23 (23.7%) 49 (50.5%) 15 (15.5%) 11 (11.3%) 
Northeastern
4 484 1985-2005 259 (53.5%) 225 (46.5%) 302 (62.4%) 109 (22.5%) 205 (42.3%) 108 (22.3%) 22 (4.5%) 
Northeastern
5 245 1980-1999 187(76.3%) 58 (23.7%) 199 (81.2%) 46 (18.8%) 168 (68.6%) 13 (5.3%) 11 (4.5%) 
Ito et al (2005)1, Vargas et al (2002)2, present study3, Moreira et al (2009)4, Lima et al (2005)5. 
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DISCUSSÃO GERAL 
 A Fundação Centro de Controle de Oncologia (FCECON) realiza o atendimento dos 
pacientes com neoplasias malignas e, em muitos casos, de neoplasias benignas. Localizada na 
cidade de Manaus, é o único hospital dedicado ao tratamento de pacientes com câncer no Estado 
do Amazonas, tornando-se uma referência na região Norte. Outro hospital que realiza 
atendimento aos pacientes oncológicos é o Hospital Ophyr Loyola em Belém – PA e o Hospital 
Regional de Santarém que desde 2008 vem realizando tratamento quimio e radioterápico. 
Similar a este estudo, Parkins et al. (2008) achou um maior número de neoplasias 
malignas quando comparado as neoplasias benignas. Os autores relataram que as neoplasias 
benignas eram mais comuns aos pacientes mais jovens e as neoplasias malignas aos pacientes 
mais velhos.  Quando avaliamos a media de idade deste estudo para neoplasias malignas (52,6 
anos de idade) e para as neoplasias benignas (36,5 anos de idade) deste estudo, constatamos a 
mesma distribuição. 
 As barreiras geográficas da maioria das cidades do interior do Amazonas fazem com que 
o acesso a determinadas cidades sejam apenas por via fluvial. Esse fato resulta em um difícil 
acesso a algumas cidades cuja viagem pode demorar mais de 15 dias. Outro agravante encontrado 
é que na época da vazante muitas cidades ficam isoladas, sem meio de transporte e 
consequentemente sem possibilidade de locomoção a outras cidades. Muitas comunidades e 
cidades menores dependem das cidades maiores para o primeiro atendimento na área de saúde, 
onde existe a carência de profissionais da área da saúde. 
 O Amazonas é conhecido ainda, por ter na sua população algumas etnias indígenas, esses 
também são atendidos no FCECON, no entanto dependendo da etnia, muitos se recusam ao 
tratamento, pois quando o mesmo causa mutilação, os mesmos não são aceitos de volta na sua 
aldeia.  Os índios que não podem colaborar com a aldeia são abandonados por ela. 
A prevenção através do exame da cavidade bucal é tradicionalmente preferido no 
diagnóstico de lesões por não ser uma técnica invasiva e ser de fácil execução. Segundo Steele e 
Meyers (2011), o uso do exame bucal como programa de detecção de lesões em estágio precoce é 
controverso, pois os mesmos afirmam que há evidências insuficientes que suportem ou refutem, 
como mostra o estudo de Sankaranarayanan et al. (2005).  No entanto, esse mesmo estudo 
mostrou uma melhora na sobrevida dos pacientes diagnosticados com câncer bucal. 
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CONCLUSÕES 
 As adversidades encontradas no Estado do Amazonas levam ao atraso do 
diagnóstico de muitas doenças e lesões, fazendo com que haja o diagnóstico tardio. Além disso, o 
acompanhamento desses pacientes após a alta hospitalar é sempre prejudicada pela distância, pois 
muitos não retornam. As lesões malignas foram mais incidentes nesse estudo e dentre elas o 
carcinoma de células escamosas, onde muitos pacientes já tinham dois ou mais sítios anatômicos 
envolvidos e a maioria desses pacientes eram do interior do Amazonas ou de outros Estados, isso 
nos leva a  acreditar que houve o atraso no diagnóstico da lesão, por carência de profissionais ou 
pela dificuldade de diagnóstico devido as barreiras geográficas. 
A alta prevalência encontrada de câncer bucal, a despeito dos baixos índices de tabagismo 
e etilismo, mostra que é necessário que as autoridades competentes iniciem campanhas de 
prevenção para a população em geral e viabilize o atendimento de saúde nas áreas menos 
favorecidas do Estado. 
Quando os tumores de glândula salivares foram analisados, o adenoma pleomórfico 
apresentou maior preval ência. Existem na literatura relatos do seu potencial de transformação 
maligna. Sendo assim, se faz necessário uma conscientização dos profissionais da área de saúde 
do Estado do Amazonas para que possa ser diagnosticado e tratado precocemente. 
Alguns prontuários não traziam o laudo histopatológico, apenas a anotação do 
profissional da área de saúde. Por serem realizados em outra instituição, não puderam ser 
confirmados. A falta de dados em muitos prontuários pesquisados reflete a falta de conhecimento 
da importância desse por parte dos profissionais da área de saúde no Amazonas, isso levou a 
exclusão de muitos prontuários, que poderiam ter contribuído com esse estudo. Como melhoria 
reuniões frequentes com orientações e a melhoria da ficha de anamnese do prontuário deveria ser 
estudada. 
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Anexo 1 
 
 
METODOLOGIA GERAL 
 
Foi realizado um estudo retrospectivo com prontuários dos pacientes atendidos nos 
serviços de Cabeça e Pescoço e de Odontologia da Fundação Centro de Controle de Oncologia do 
Estado do Amazonas (FCECON) de janeiro de 1998 a dezembro de 2009.  
Para determinar o objeto do estudo, foram estabelecidos os seguintes critérios: de inclusão 
deveria haver a presença de lesão bucal; e o de exclusão foram o preenchimento incorreto do 
prontuário e/ou a incapacidade de verificar o diagnóstico do exame histopatológico.  
O projeto inicial foi aprovado pelo Comitê de Ética e Pesquisa (CEP) da Universidade do 
Estado do Amazonas (UEA) sob o protocolo de número 143/09 (Anexo 2). Os dados foram 
coletados num formulário (Anexo 3) previamente estabelecido visando gênero, idade, local de 
nascimento, município de residência, raça, hábitos, localização da lesão, diagnóstico 
histopatológico e tratamento. 
 Todos os procedimentos estatísticos foram realizados no programa Statistica versão 5.1 
(StatSoft Inc., Tulsa, USA). Os dados qualitativos foram descritos por meio de frequência 
absoluta (n) e relativa (%). A variável idade foi descrita pela média. 
 Para comparação entre os grupos, quando o ―n‖ era menor que 20, ou quando o valor 
ficava entre 20 e 40 e a casela com a menor freqüência esperada tinha valor menor ou igual a 5, 
utilizou-se o Teste Exato de Fisher. Nas outras situações utilizou-se o teste do qui-quadrado. Em 
todos os testes adotou-se nível de significância de 5% (p<0,05). 
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Anexo 2 
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Anexo 3 
 
FICHA DE COLETA DA DADOS 
 
NOME: 
DATA DO 1o ATENDIMENTO:____/____/________                                          RH: 
IDENTIFICAÇÃO: 
Endereço 
Bairro: CEP: Cidade: UF: 
Tel: Rec: Naturalidade(cidade): 
Data de nascimento: ____/____/________ Profissão: 
Cor: Branca Negra Indígena Gênero: (    )M    (    )F 
HISTÓRIA MÉDICA: 
 
 
Vícios: Fumo   Ácool   Droga NãoEV    Droga EV 
Frequência: 
EXAME FÍSICO INTRABUCAL: 
Localização da lesão: 
DIAGNÓSTICO HISTOPATOLÓGICO: 
 
TRATAMENTO: 
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Anexo 4 
(Appendix 1) 
 
 
Table 5 - Distribution of patients treated at FCECON by non-neoplastic proliferative lesions 
and gingival pathology and gender (1998-2009 period). 
 
Diagnosis 
M F 
p 
M+F 
n % n % n % mean age 
Pyogenic granuloma 7 53.8 18 46.2 0.752 ns 25 48.1 34.2 
Focal fibrous hyperplasia 6 46.2 18 46.2 1.000 ns 24 46.2 44.4 
Peripheral ossifying fibroma 0 0.0 2 5.1 1.000 ns 2 3.8 60.0 
Gingival hyperplasia 0 0.0 1 2.6 1.000 ns 1 1.9 28.0 
TOTAL 13 100.0 39 100.0  52 100.0  41.6 
ns – no statistically significant difference between the gender 
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Anexo 5 
(Appendix 2) 
 
 
Table 6 - Distribution of patients treated at FCECON by salivary gland pathology excluding 
neoplasia and gender (1998-2009 period). 
 
Diagnosis 
M F 
p 
M+F 
n % n % n % mean age 
Sialadenitis 5 33.3 3 25.0 0.696 ns 8 29.6 37.1 
Ranula 3 20.0 2 16.7 1.000 ns 5 18.5 17.8 
Mucocele 2 13.3 2 16.7 1.000 ns 4 14.8 15.5 
Sialolithiasis 3 20.0 0 0.0 0.230 ns 3 11.1 51.3 
Epidermal cyst 0 0.0 2 16.7 0.188 ns 2 7.4 30.0 
Benign lymphoepithelial lesion 1 6.7 1 8.3 1.000 ns 2 7.4 43.5 
Sjögren’s syndrome 0 0.0 2 16.7 0.188 ns 2 7.4 47.5 
Sialosis 1 6.7 0 0.0 1.000 ns 1 3.7 63.0 
TOTAL 15 100.0 12 100.0   27 100.0 38.2 
ns – no statistically significant difference between the gender 
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Anexo 6 
(Appendix 3) 
 
 
Table 7 - Distribution of patients treated at FCECON Bone and connective tissue pathology and 
gender (1998-2009 period). 
 
Diagnosis 
M F 
p 
M+F 
n % n % n % mean age 
Bone pathology         
Fibrous dysplasia 2 20.0 2 28.6 1.000 ns 4 23.5 23.5 
Ossifying fibroma 4 40.0 3 42.9 1.000 ns 7 41.2 41.2 
Osteomielytis 2 20.0 0 0.0 0.485 ns 2 11.8 11.8 
Central giant cell granuloma 2 20.0 2 28.6 1.000 ns 4 23.5 23.5 
Sub-total 10 100.0 7 100.0   17 100.0 100.0 
Connective tissue pathology         
Haemangioma – capillary 1 50.0 4 57.1 1.000 ns 5 55.6 55.6 
Haemangioma – cavernous 1 50.0 2 28.6 1.000 ns 3 33.3 33.3 
Normal tissue 0 0.0 1 14.3 1.000 ns 1 11.1 11.1 
Sub-total 2 100.0 7 100.0   9 100.0 100.0 
TOTAL 12   14     26     
ns – no statistically significant difference between the gender 
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Anexo 7 
(Appendix 4) 
 
Table 8 - Distribution of patients treated at FCECON by odontogenic tumors and cysts and 
gender (1998-2009 period). 
 
Diagnosis 
M F 
p 
M+F 
n % n % n % mean age 
Odontogenic tumor         
Ameloblastoma 3 37.5 4 50.0 1.000 ns 7 43.8 31.9 
keratocistic odontogenic tumour 3 37.5 1 12.5 0.569 ns 4 25.0 38.8 
Odontogenic myxoma 0 0.0 2 25.0 0.467 ns 2 12.5 62.0 
Calcifying epithelial odontogenic 
tumour 
1 12.5 0 0.0 1.000 ns 1 6.3 12.0 
Adenomatoid odontogenic 
tumour 
1 12.5 0 0.0 1.000 ns 1 6.3 35.0 
Odontogenic fibroma 0 0.0 1 12.5 1.000 ns 1 6.3 19.0 
Sub-total 8 100.0 8 100.0   16 100.0 33.1 
Odontogenic cysts         
Dentigerous cyst 3 75.0 2 66.7 1.000 ns 5 71.4 25.2 
Calcifying odontogenic cyst 0 0.0 1 33.3 0.428 ns 1 14.3 32.0 
Odontogenic cyst – unclassified 1 25.0 0 0.0 1.000 ns 1 14.3 42.0 
Sub-total 4 100.0 3 100.0   7 100.0 33.1 
TOTAL 12   11     23     
ns – no statistically significant difference between the gender 
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Anexo 8 
(Appendix 5) 
 
 
Table 9 - Distribution of patients treated at FCECON by mucosal and skin pathology and gender 
(1998-2009 period). 
 
Diagnosis 
M F 
p 
M+F 
n % n % n % mean age 
Leucoplakia 3 37.5 2 22.2 0.620 ns 5 29.4 59.6 
Epithelial hyperplasia 1 12.5 3 33.3 0.576 ns 4 23.5 47.8 
Melanocytic nevus 1 12.5 1 11.1 1.000 ns 2 11.8 28.0 
Paracoccidiodomycosis 1 12.5 1 11.1 1.000 ns 2 11.8 50.0 
Ectodermal dysplasia 0 0.0 1 11.1 1.000 ns 1 5.9 13.0 
Epidermolysis bullosa 1 12.5 0 0.0 0.471 ns 1 5.9 6.0 
Papillary hyperplasia 0 0.0 1 11.1 1.000 ns 1 5.9 71.0 
Lichen planus 1 12.5 0 0.0 0.471 ns 1 5.9 64.0 
TOTAL 8 100.0 9 100.0   17 100.0 42.4  
ns – no statistically significant difference between the gender 
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Anexo 9 
(Appendix 6) 
 
 
Table 10 - Distribution of patients treated at FCECON for other diagnosed diseases by type and 
gender (1998-2009 period). 
 
Diagnosis 
M F 
p 
M+F 
n % n % n % mean age 
Miscellaneous pathology         
Ectopic thyroid 1 33.3 0 0.0 - 1 33.3 8.0 
Leishmaniasis 1 33.3 0 0.0 - 1 33.3 45.0 
Chronic lymphadenitis 1 33.3 0 0.0 - 1 33.3 19.0 
Sub-total 3 100.0 0 0.0   3 100.0   
Non-odontogenic cyst         
Lymphoepithelial cyst 0 0.0 1 100.0 - 1 100.0 34.0 
TOTAL 3   1     4     
ns – no statistically significant difference between the gender 
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Anexo 10 
Table 11 - Histological classification and site of pathologies. 
   Floor  Sub-  Buccal   Retromolar  
Two 
or Other    
PATHOLOGY Tongue Parotid 
of the 
mouth mandibular Palate mucosa Lips Gengiva 
trigone 
area 
Vestibul
e 
more 
sites mouth Mandible Maxilla TOTAL 
Squamous cell carcinoma 68  29 1 30 9 13 10 1  45 10   216 
Acinic cell carcinoma  1 1            2 
Mucoepidermoid 
carcinoma  4 1  3    1  2    11 
Adenoid cystic carcinoma 2 2 4 2 3 2         15 
Adenocarcinoma           2    2 
Carcinoma in 
pleomorphic adenoma  2   2          4 
Malignant lymphomas 1 2         1    3 
Myoepithelial carcinoma  1             1 
Non-Hodgkin's 
lymphoma    1       1    2 
Melanoma     2 1     1    4 
Metastatic carcinoma         1      1 
Carcinoma - 
Undifferentiated  2  1           3 
Plasmocytoma             2  2 
Rhabdomyosarcoma           2    2 
Angiosarcoma  1             1 
Langerhans cell 
histiocytosis           2    2 
Malignant disease - 
undifferentiated             1  1 
Osteosarcoma               1 1 
Sarcoma           1    1 
Carcinoma in situ   1            1 
Myoepithelial carcinoma  1             1 
Pleomorfic adenoma 1 36  9 2  1        49 
Myoepithelioma  2             2 
Basal cell adenoma  2             2 
Warthin tumor  3  1           4 
Focal fibrous hyperplasia 2     7 5 1       15 
Squamous papillomas 3    1   7       11 
Lymphangioma 1  1 1       1    4 
Fibrous histiocytoma  1     1        2 
 68 
   Floor  Sub-  Buccal   Retromolar  
Two 
or Other    
PATHOLOGY Tongue Parotid 
of the 
mouth mandibular Palate mucosa Lips Gengiva 
trigone 
area 
Vestibul
e 
more 
sites mouth Mandible Maxilla TOTAL 
Haemangiopericytoma           1    1 
Meningioma              1 1 
Neurofibroma   1            1 
Melanotic 
neuroectodermal tumor of 
infancy           1    1 
Pyogenic granuloma 5    2 3 2 7 1      20 
Fibrous epulis 1  1  3 1 1 15  3     25 
Peripheral ossifying 
fibroma             1  1 
Gingival hyperplasia        1       1 
Sialadenitis  1  6           7 
Mucocele and ranula   5  1  3        9 
Sialolithiasis   1            1 
Epidermal cyst  1             1 
Benign lymphoepitelial 
lesion  1  2           3 
Sjögren syndrome    2           2 
Sialosis    1         3  4 
Fibrous displasia             1 3 4 
Ossifying fibroma             4 3 7 
Osteomielytis             2  2 
Central giant cell 
granuloma             3 1 4 
Haemangioma - capillary 2      2 1       5 
Haemangioma - 
cavernous 3              3 
Normal tissue            1   1 
Ameloblastoma             6 1 7 
Keratocistic odontogenic 
tumour             3 1 4 
Odontogenic myxoma             1 1 2 
Calcifying epithelial 
odontogenic tumour              1 1 
Adenomatoid 
odontogenic tumour              1 1 
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   Floor  Sub-  Buccal   Retromolar  
Two 
or Other    
PATHOLOGY Tongue Parotid 
of the 
mouth mandibular Palate mucosa Lips Gengiva 
trigone 
area 
Vestibul
e 
more 
sites mouth Mandible Maxilla TOTAL 
Calcifying odontogenic 
cyst             4 1 5 
Dentigerous cyst             1  1 
Odontogenic cyst - 
unclassified              1 1 
Ectodermal dysplasia            1   1 
Epidermolysis bullosa       1        1 
Leucoplakia      2 1 2       5 
Melanocytic nevus     1   1       2 
Paracoccidiodomycosis    1   1        2 
Epithelial hyperplasia      1 1 2       4 
Papillary hyperplasia 1              1 
Lichen planus      1         1 
Ectopic thyroid 1              1 
Leishmaniasis              1 1 
Chroinic lymphadenitis    1           1 
Lymphoepithelial cyst  1             1 
TOTAL 91 65 46 30 50 27 32 48 4 3 61 12 32 18 518 
 
 
